Premier Alternatives

A.D.A.M. Innovations

Tokyo, Japan · Founded 2004 · Privately Held (backing)

Provider of genetic research and testing services intended to offer clinically validated genetic testing. A.D.A.M. Innovations is based in Tokyo, Japan and was founded in 2004. It was valued at $389 million at its later-stage round in Feb 2018, the last priced event on record. It has raised $47.4 million across 5 recorded rounds; the latest was a later-stage round in Mar 2026.

PMV mark · valuation
$388.7M
Oct 2026
Priced at
its later-stage round
Feb 2018
Total raised
$47.4M
Last round
Later Stage VC
Mar 2026

A.D.A.M. Innovations key facts

as of Oct 2026
  • Provider of genetic research and testing services intended to offer clinically validated genetic testing.
  • A.D.A.M. Innovations is valued at approximately $388.7M as of Oct 2026, set at its later-stage round, Feb 2018; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $47.4M across 5 recorded rounds; the latest was Later Stage VC in Mar 2026.
  • Notable investors include Mitsui & Co, Rakuten Capital, Crewstone International, Tokyo Founders Fund, Ci:z Investment — 6 tracked in total.
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$388.7M

Valued at $388.7M at its later-stage round, Feb 2018. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of A.D.A.M. Innovations with a free account
  • ·The post-money valuation on its round
  • ·Everyone on the team, board and advisors included
  • ·Watch A.D.A.M. Innovations: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

A.D.A.M. Innovations funding rounds

5 rounds
Mar 2026Later Stage VC—▮
Jul 2019Later Stage VC$13.4M▮
Feb 2018Later Stage VC$15.3M▮
Aug 2017Later Stage VC$12.7M▮
Nov 2015Seed Round$6.0M▮
Full funding history →

A.D.A.M. Innovations leadership

A.D.A.M. Innovations valuation

A.D.A.M. Innovations was valued at $389 million at its later-stage round in Feb 2018. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has A.D.A.M. Innovations raised?

A.D.A.M. Innovations has raised $47.4 million across 5 recorded rounds since 2015. The largest was a $6 million seed round in Nov 2015; the most recent was a later-stage round in Mar 2026. 1 of the rounds disclosed a post-money valuation.

A.D.A.M. Innovations investors

6 investors are on record for A.D.A.M. Innovations, including Mitsui & Co, Rakuten Capital, Crewstone International and Tokyo Founders Fund. The later-stage round in Mar 2026 drew 1 investor.

Who runs A.D.A.M. Innovations

10 people are listed on the A.D.A.M. Innovations team: 6 executives and 4 board members, including David Baran (Co-Founder) and Iri Baran Ph.D (Co-Founder). 5 of them have a verified direct contact on file.

About A.D.A.M. Innovations

Provider of genetic research and testing services intended to offer clinically validated genetic testing. The company's services include consumer-based testing, diagnostic testing, and gene therapy, using polymerase chain reaction, microarray, or sequencing technologies, and also provides a range of at-home DNA test kits, enabling patients to achieve health and wellness goals.

Sector
Healthcare
HQ
Tokyo, Japan
Founded
2004
Employees
50
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.